文献速递肺外科

影像与手术间隔时间并非临床IA期非小细胞肺癌升期的危险因素

Time between imaging and surgery is not a risk factor for upstaging of clinical stage IA non-small-cell lung cancer.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

该单中心回顾性研究纳入2015年1月至2022年9月接受手术的622例临床T1N0M0非小细胞肺癌患者,按CT至手术间隔分为<30天、30-59天和≥60天三组,分析不同结节亚型肿瘤升期与时间的关系。结果显示间隔时间与任何结节亚型的升期均无显著关联,作者认为需进一步研究升期的危险因素。

要点

  • 622例临床T1N0M0非小细胞肺癌患者中,CT至手术间隔<30天228例(36.7%)、30-59天242例(38.9%)、≥60天152例(24.4%)。
  • CT至手术间T分期升高346例(55.6%),其中磨玻璃结节126例(36.4%)、部分实性结节147例(42.5%)、实性结节73例(21.1%)。
  • CT至手术间隔长度与任何结节亚型的升期均无显著关联(全队列P=0.903;磨玻璃结节P=0.880;部分实性结节P=0.858;实性结节P=0.959)。

核心结论

  • 该单中心经验提示,临床IA期非小细胞肺癌患者肿瘤升期与影像至肺切除时间无显著关联,需进一步研究以更好地理解升期的危险因素。

研究设计与样本

  • 单中心回顾性研究,回顾本机构数据库,纳入2015年1月至2022年9月因临床分期T1N0M0非小细胞肺癌接受手术的患者622例。

主要发现

  • CT至手术间隔<30天228例(36.7%)、30-59天242例(38.9%)、≥60天152例(24.4%),各组患者或结节特征无差异。
  • CT至手术间T分期升高346例(55.6%),其中磨玻璃结节126例(36.4%)、部分实性结节147例(42.5%)、实性结节73例(21.1%)。
  • CT至手术间隔长度与任何结节亚型的升期均无显著关联(全队列P=0.903;磨玻璃结节P=0.880;部分实性结节P=0.858;实性结节P=0.959)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文自述为单中心经验。
  • 原文结论指出需进一步研究以更好地理解升期的危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The timing of preoperative imaging in patients with lung cancer is a debated topic, as there are limited data on cancer progression during the interval between clinical staging by imaging and pathological staging after resection. We quantified disease progression during this interval in patients with early stage non-small-cell lung cancer (NSCLC) to better understand if its length impacts upstaging. METHODS: We retrospectively reviewed our institutional database to identify patients who underwent surgery for clinically staged T1N0M0 NSCLC from January 2015 through September 2022. Tumour upstaging between chest computed tomography (CT) and surgery were analysed as a function of time (<30, 30-59, ≥60 days) for different nodule subtypes. We analysed data across 3 timeframes using Pearson's chi-squared and analysis of variance tests. RESULTS: During the study period, 622 patients underwent surgery for clinically staged T1N0M0 NSCLC. CT-to-surgery interval was <30 days in 228 (36.7%), 30-59 days in 242 (38.9%) and ≥60 days in 152 (24.4%) with no differences in patient or nodule characteristics observed between these groups. T-stage increased in 346 patients (55.6%) between CT imaging and surgery. Among these patients, 126 (36.4%) had ground-glass nodules, 147 (42.5%) had part-solid nodules and 73 (21.1%) had solid nodules. CT-to-surgery interval length was not associated with upstaging of any nodule subtype (full-cohort, P = 0.903; ground-glass, P = 0.880; part-solid, P = 0.858; solid, P = 0.959). CONCLUSIONS: This single-centre experience suggests no significant association between tumour upstaging and time from imaging to lung resection in patients with clinical stage IA NSCLC. Further studies are needed to better understand the risk factors for upstaging.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Barcelos RR, Sugarbaker E, Kennedy KF, et al. Time between imaging and surgery is not a risk factor for upstaging of clinical stage IA non-small-cell lung cancer. Eur J Cardiothorac Surg. 2024. PMID: 38407382. doi:10.1093/ejcts/ezae057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。